NF-κB constitutive activation is considered to be a signature also in several haematological malignancies, and in many of them, including activated B‐cell‐like (ABC)-diffuse large B‐cell lymphoma (DLBCL) and multiple myeloma (MM), it promotes cancer cell survival17,21,29. Here, NFKB1 is linked to diffuse large B-cell lymphoma.